HEADER ISOMERASE/ISOMERASE INHIBITOR 13-NOV-12 4HYM TITLE PYRROLOPYRIMIDINE INHIBITORS OF DNA GYRASE B AND TOPOISOMERASE IV, TITLE 2 PART I: STRUCTURE GUIDED DISCOVERY AND OPTIMIZATION OF DUAL TARGETING TITLE 3 AGENTS WITH POTENT, BROAD-SPECTRUM ENZYMATIC ACTIVITY. COMPND MOL_ID: 1; COMPND 2 MOLECULE: TOPOISOMERASE IV, SUBUNIT B; COMPND 3 CHAIN: A, B; COMPND 4 EC: 5.99.1.3; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: FRANCISELLA TULARENSIS SUBSP. HOLARCTICA LVS; SOURCE 3 ORGANISM_TAXID: 376619; SOURCE 4 STRAIN: LVS; SOURCE 5 GENE: FTL_1726; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS ATP-BINDING, NUCLEOTIDE-BINDING, TOPOISOMERASE, ATP-BINDING DOMAIN, KEYWDS 2 ISOMERASE-ISOMERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR D.C.BENSEN,C.J.CREIGHTON,B.KWAN,L.W.TARI REVDAT 3 28-FEB-24 4HYM 1 REMARK SEQADV SHEET REVDAT 2 27-FEB-13 4HYM 1 JRNL REVDAT 1 13-FEB-13 4HYM 0 JRNL AUTH L.W.TARI,M.TRZOSS,D.C.BENSEN,X.LI,Z.CHEN,T.LAM,J.ZHANG, JRNL AUTH 2 C.J.CREIGHTON,M.L.CUNNINGHAM,B.KWAN,M.STIDHAM,K.J.SHAW, JRNL AUTH 3 F.C.LIGHTSTONE,S.E.WONG,T.B.NGUYEN,J.NIX,J.FINN JRNL TITL PYRROLOPYRIMIDINE INHIBITORS OF DNA GYRASE B (GYRB) AND JRNL TITL 2 TOPOISOMERASE IV (PARE). PART I: STRUCTURE GUIDED DISCOVERY JRNL TITL 3 AND OPTIMIZATION OF DUAL TARGETING AGENTS WITH POTENT, JRNL TITL 4 BROAD-SPECTRUM ENZYMATIC ACTIVITY. JRNL REF BIOORG.MED.CHEM.LETT. V. 23 1529 2013 JRNL REFN ISSN 0960-894X JRNL PMID 23352267 JRNL DOI 10.1016/J.BMCL.2012.11.032 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.6.0117 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.43 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 3 NUMBER OF REFLECTIONS : 66593 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.240 REMARK 3 R VALUE (WORKING SET) : 0.238 REMARK 3 FREE R VALUE : 0.276 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 3543 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.95 REMARK 3 REFLECTION IN BIN (WORKING SET) : 4830 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.97 REMARK 3 BIN R VALUE (WORKING SET) : 0.3040 REMARK 3 BIN FREE R VALUE SET COUNT : 250 REMARK 3 BIN FREE R VALUE : 0.3350 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4637 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 30 REMARK 3 SOLVENT ATOMS : 634 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 37.92 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.97000 REMARK 3 B22 (A**2) : 1.15000 REMARK 3 B33 (A**2) : -0.11000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.26000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.158 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.151 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.108 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.636 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.936 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.918 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4774 ; 0.012 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6451 ; 1.552 ; 1.972 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 586 ; 5.689 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 210 ;35.680 ;26.000 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 892 ;16.323 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 11 ; 6.636 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 731 ; 0.122 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3506 ; 0.008 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4HYM COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-NOV-12. REMARK 100 THE DEPOSITION ID IS D_1000076082. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-JUL-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 4.2.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : NOIR-1 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : D*TREK REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 70176 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 43.430 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.08200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.97 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.1 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.41400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.71 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.60 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10% PEG 4000, 10% ISOPROPANOL, 100 MM REMARK 280 CITRATE , PH 5.4, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 65.14100 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 GLN A 2 REMARK 465 ASN A 3 REMARK 465 TYR A 4 REMARK 465 ASN A 5 REMARK 465 ALA A 6 REMARK 465 LYS A 102 REMARK 465 ASN A 103 REMARK 465 TYR A 104 REMARK 465 THR A 105 REMARK 465 HIS A 106 REMARK 465 SER A 107 REMARK 465 LEU A 299 REMARK 465 SER A 300 REMARK 465 VAL A 301 REMARK 465 LYS A 302 REMARK 465 ARG A 378 REMARK 465 ILE A 379 REMARK 465 ASN A 380 REMARK 465 ALA A 381 REMARK 465 ASP A 382 REMARK 465 LEU A 383 REMARK 465 GLU A 384 REMARK 465 HIS A 385 REMARK 465 HIS A 386 REMARK 465 HIS A 387 REMARK 465 HIS A 388 REMARK 465 HIS A 389 REMARK 465 HIS A 390 REMARK 465 MET B 1 REMARK 465 GLN B 2 REMARK 465 ASN B 3 REMARK 465 TYR B 4 REMARK 465 ASN B 5 REMARK 465 ALA B 6 REMARK 465 LYS B 7 REMARK 465 ASN B 101 REMARK 465 LYS B 102 REMARK 465 ASN B 103 REMARK 465 TYR B 104 REMARK 465 THR B 105 REMARK 465 HIS B 106 REMARK 465 SER B 107 REMARK 465 GLY B 108 REMARK 465 GLY B 109 REMARK 465 LEU B 110 REMARK 465 HIS B 111 REMARK 465 GLY B 112 REMARK 465 GLU B 234 REMARK 465 PRO B 235 REMARK 465 PHE B 236 REMARK 465 ILE B 237 REMARK 465 ILE B 238 REMARK 465 ASP B 239 REMARK 465 ASN B 240 REMARK 465 PHE B 241 REMARK 465 SER B 242 REMARK 465 ASN B 243 REMARK 465 GLY B 244 REMARK 465 ASP B 245 REMARK 465 SER B 246 REMARK 465 TYR B 247 REMARK 465 LEU B 248 REMARK 465 ASP B 249 REMARK 465 ALA B 250 REMARK 465 VAL B 251 REMARK 465 PHE B 252 REMARK 465 CYS B 253 REMARK 465 TRP B 254 REMARK 465 CYS B 255 REMARK 465 GLU B 256 REMARK 465 ASP B 257 REMARK 465 PRO B 258 REMARK 465 SER B 259 REMARK 465 GLU B 260 REMARK 465 VAL B 267 REMARK 465 GLN B 274 REMARK 465 ASP B 275 REMARK 465 GLY B 276 REMARK 465 THR B 277 REMARK 465 HIS B 278 REMARK 465 VAL B 279 REMARK 465 THR B 280 REMARK 465 GLY B 281 REMARK 465 LEU B 282 REMARK 465 LYS B 283 REMARK 465 ASN B 284 REMARK 465 GLY B 285 REMARK 465 ILE B 286 REMARK 465 TYR B 287 REMARK 465 ASP B 288 REMARK 465 ALA B 289 REMARK 465 ILE B 290 REMARK 465 LYS B 291 REMARK 465 ALA B 292 REMARK 465 TYR B 293 REMARK 465 ILE B 294 REMARK 465 GLU B 295 REMARK 465 LYS B 296 REMARK 465 ASN B 297 REMARK 465 SER B 298 REMARK 465 LEU B 299 REMARK 465 SER B 300 REMARK 465 VAL B 301 REMARK 465 LYS B 302 REMARK 465 ASN B 303 REMARK 465 ILE B 304 REMARK 465 LYS B 305 REMARK 465 ILE B 306 REMARK 465 THR B 307 REMARK 465 ALA B 308 REMARK 465 ASN B 309 REMARK 465 ASP B 310 REMARK 465 SER B 311 REMARK 465 PHE B 312 REMARK 465 ALA B 313 REMARK 465 GLN B 314 REMARK 465 LEU B 315 REMARK 465 ASN B 316 REMARK 465 TYR B 317 REMARK 465 VAL B 318 REMARK 465 ILE B 319 REMARK 465 SER B 320 REMARK 465 VAL B 321 REMARK 465 LYS B 322 REMARK 465 ILE B 323 REMARK 465 THR B 324 REMARK 465 ASN B 325 REMARK 465 PRO B 326 REMARK 465 GLN B 327 REMARK 465 PHE B 328 REMARK 465 ALA B 329 REMARK 465 GLY B 330 REMARK 465 GLN B 331 REMARK 465 THR B 332 REMARK 465 LYS B 333 REMARK 465 GLU B 334 REMARK 465 LYS B 335 REMARK 465 LEU B 336 REMARK 465 SER B 337 REMARK 465 ASN B 338 REMARK 465 LYS B 339 REMARK 465 ASP B 340 REMARK 465 VAL B 341 REMARK 465 THR B 342 REMARK 465 ASN B 343 REMARK 465 PHE B 344 REMARK 465 VAL B 345 REMARK 465 ALA B 346 REMARK 465 THR B 347 REMARK 465 ALA B 348 REMARK 465 VAL B 349 REMARK 465 LYS B 350 REMARK 465 ASP B 351 REMARK 465 LEU B 352 REMARK 465 LEU B 353 REMARK 465 THR B 354 REMARK 465 ILE B 355 REMARK 465 TRP B 356 REMARK 465 LEU B 357 REMARK 465 ASN B 358 REMARK 465 GLN B 359 REMARK 465 ASN B 360 REMARK 465 PRO B 361 REMARK 465 ASP B 362 REMARK 465 GLU B 363 REMARK 465 ALA B 364 REMARK 465 ARG B 365 REMARK 465 GLN B 366 REMARK 465 ILE B 367 REMARK 465 VAL B 368 REMARK 465 GLU B 369 REMARK 465 ASN B 370 REMARK 465 ILE B 371 REMARK 465 SER B 372 REMARK 465 LYS B 373 REMARK 465 VAL B 374 REMARK 465 ALA B 375 REMARK 465 GLN B 376 REMARK 465 LYS B 377 REMARK 465 ARG B 378 REMARK 465 ILE B 379 REMARK 465 ASN B 380 REMARK 465 ALA B 381 REMARK 465 ASP B 382 REMARK 465 LEU B 383 REMARK 465 GLU B 384 REMARK 465 HIS B 385 REMARK 465 HIS B 386 REMARK 465 HIS B 387 REMARK 465 HIS B 388 REMARK 465 HIS B 389 REMARK 465 HIS B 390 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 N ASN A 325 O HOH A 602 1.87 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 226 -80.37 -106.35 REMARK 500 GLU A 227 99.78 -5.18 REMARK 500 ALA A 228 140.37 26.36 REMARK 500 ASP A 275 -134.72 56.52 REMARK 500 LYS A 305 63.72 -100.22 REMARK 500 LEU B 15 -22.45 81.83 REMARK 500 GLU B 80 -48.55 -179.53 REMARK 500 HIS B 94 44.19 -104.66 REMARK 500 CYS B 194 89.53 -154.39 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CJC A 401 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4HXZ RELATED DB: PDB REMARK 900 RELATED ID: 4HY1 RELATED DB: PDB REMARK 900 RELATED ID: 4HZ5 RELATED DB: PDB REMARK 900 RELATED ID: 4HZ0 RELATED DB: PDB REMARK 900 RELATED ID: 4HYP RELATED DB: PDB REMARK 900 RELATED ID: 4GGL RELATED DB: PDB REMARK 900 RELATED ID: 4GFN RELATED DB: PDB REMARK 900 RELATED ID: 4GEE RELATED DB: PDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE RESIDUE AT THIS POSITION INDICATES A NATURAL VARIANT DBREF 4HYM A 1 382 UNP Q2A1P5 Q2A1P5_FRATH 1 382 DBREF 4HYM B 1 382 UNP Q2A1P5 Q2A1P5_FRATH 1 382 SEQADV 4HYM PRO A 258 UNP Q2A1P5 LEU 258 SEE REMARK 999 SEQADV 4HYM LEU A 383 UNP Q2A1P5 EXPRESSION TAG SEQADV 4HYM GLU A 384 UNP Q2A1P5 EXPRESSION TAG SEQADV 4HYM HIS A 385 UNP Q2A1P5 EXPRESSION TAG SEQADV 4HYM HIS A 386 UNP Q2A1P5 EXPRESSION TAG SEQADV 4HYM HIS A 387 UNP Q2A1P5 EXPRESSION TAG SEQADV 4HYM HIS A 388 UNP Q2A1P5 EXPRESSION TAG SEQADV 4HYM HIS A 389 UNP Q2A1P5 EXPRESSION TAG SEQADV 4HYM HIS A 390 UNP Q2A1P5 EXPRESSION TAG SEQADV 4HYM PRO B 258 UNP Q2A1P5 LEU 258 SEE REMARK 999 SEQADV 4HYM LEU B 383 UNP Q2A1P5 EXPRESSION TAG SEQADV 4HYM GLU B 384 UNP Q2A1P5 EXPRESSION TAG SEQADV 4HYM HIS B 385 UNP Q2A1P5 EXPRESSION TAG SEQADV 4HYM HIS B 386 UNP Q2A1P5 EXPRESSION TAG SEQADV 4HYM HIS B 387 UNP Q2A1P5 EXPRESSION TAG SEQADV 4HYM HIS B 388 UNP Q2A1P5 EXPRESSION TAG SEQADV 4HYM HIS B 389 UNP Q2A1P5 EXPRESSION TAG SEQADV 4HYM HIS B 390 UNP Q2A1P5 EXPRESSION TAG SEQRES 1 A 390 MET GLN ASN TYR ASN ALA LYS SER ILE GLU VAL LEU THR SEQRES 2 A 390 GLY LEU ASP PRO VAL LYS LYS ARG PRO GLY MET TYR THR SEQRES 3 A 390 ASN ILE GLU ASN PRO ASN HIS LEU ILE GLN GLU ILE ILE SEQRES 4 A 390 ASP ASN SER VAL ASP GLU VAL LEU ALA GLY PHE ALA SER SEQRES 5 A 390 LYS ILE ASN ILE THR LEU TYR GLU ASP ASN SER ILE GLU SEQRES 6 A 390 VAL ALA ASP ASP GLY ARG GLY MET PRO VAL ASP ILE HIS SEQRES 7 A 390 PRO GLU HIS LYS MET SER GLY ILE GLU LEU ILE MET THR SEQRES 8 A 390 LYS LEU HIS SER GLY GLY LYS PHE SER ASN LYS ASN TYR SEQRES 9 A 390 THR HIS SER GLY GLY LEU HIS GLY VAL GLY VAL SER VAL SEQRES 10 A 390 VAL ASN ALA LEU SER THR ARG LEU GLU ALA GLU ILE LYS SEQRES 11 A 390 ARG ASP GLY ASN VAL TYR HIS ILE VAL PHE GLU ASP GLY SEQRES 12 A 390 PHE LYS THR LYS ASP LEU GLU ILE ILE ASP ASN VAL GLY SEQRES 13 A 390 LYS LYS ASN THR GLY THR LYS ILE ARG PHE TRP PRO ASN SEQRES 14 A 390 LYS LYS TYR PHE ASP ASP ILE LYS VAL ASN PHE LYS ALA SEQRES 15 A 390 LEU LYS ASN LEU LEU GLU ALA LYS ALA ILE LEU CYS LYS SEQRES 16 A 390 ALA LEU THR ILE LYS TYR SER ASN GLU ILE LYS LYS GLU SEQRES 17 A 390 LYS LEU THR TRP HIS PHE GLU THR GLY LEU LYS GLY TYR SEQRES 18 A 390 LEU ASP HIS LYS LEU GLU ALA GLU THR LEU PRO ALA GLU SEQRES 19 A 390 PRO PHE ILE ILE ASP ASN PHE SER ASN GLY ASP SER TYR SEQRES 20 A 390 LEU ASP ALA VAL PHE CYS TRP CYS GLU ASP PRO SER GLU SEQRES 21 A 390 SER ILE LYS ASN SER TYR VAL ASN LEU ILE PRO THR PRO SEQRES 22 A 390 GLN ASP GLY THR HIS VAL THR GLY LEU LYS ASN GLY ILE SEQRES 23 A 390 TYR ASP ALA ILE LYS ALA TYR ILE GLU LYS ASN SER LEU SEQRES 24 A 390 SER VAL LYS ASN ILE LYS ILE THR ALA ASN ASP SER PHE SEQRES 25 A 390 ALA GLN LEU ASN TYR VAL ILE SER VAL LYS ILE THR ASN SEQRES 26 A 390 PRO GLN PHE ALA GLY GLN THR LYS GLU LYS LEU SER ASN SEQRES 27 A 390 LYS ASP VAL THR ASN PHE VAL ALA THR ALA VAL LYS ASP SEQRES 28 A 390 LEU LEU THR ILE TRP LEU ASN GLN ASN PRO ASP GLU ALA SEQRES 29 A 390 ARG GLN ILE VAL GLU ASN ILE SER LYS VAL ALA GLN LYS SEQRES 30 A 390 ARG ILE ASN ALA ASP LEU GLU HIS HIS HIS HIS HIS HIS SEQRES 1 B 390 MET GLN ASN TYR ASN ALA LYS SER ILE GLU VAL LEU THR SEQRES 2 B 390 GLY LEU ASP PRO VAL LYS LYS ARG PRO GLY MET TYR THR SEQRES 3 B 390 ASN ILE GLU ASN PRO ASN HIS LEU ILE GLN GLU ILE ILE SEQRES 4 B 390 ASP ASN SER VAL ASP GLU VAL LEU ALA GLY PHE ALA SER SEQRES 5 B 390 LYS ILE ASN ILE THR LEU TYR GLU ASP ASN SER ILE GLU SEQRES 6 B 390 VAL ALA ASP ASP GLY ARG GLY MET PRO VAL ASP ILE HIS SEQRES 7 B 390 PRO GLU HIS LYS MET SER GLY ILE GLU LEU ILE MET THR SEQRES 8 B 390 LYS LEU HIS SER GLY GLY LYS PHE SER ASN LYS ASN TYR SEQRES 9 B 390 THR HIS SER GLY GLY LEU HIS GLY VAL GLY VAL SER VAL SEQRES 10 B 390 VAL ASN ALA LEU SER THR ARG LEU GLU ALA GLU ILE LYS SEQRES 11 B 390 ARG ASP GLY ASN VAL TYR HIS ILE VAL PHE GLU ASP GLY SEQRES 12 B 390 PHE LYS THR LYS ASP LEU GLU ILE ILE ASP ASN VAL GLY SEQRES 13 B 390 LYS LYS ASN THR GLY THR LYS ILE ARG PHE TRP PRO ASN SEQRES 14 B 390 LYS LYS TYR PHE ASP ASP ILE LYS VAL ASN PHE LYS ALA SEQRES 15 B 390 LEU LYS ASN LEU LEU GLU ALA LYS ALA ILE LEU CYS LYS SEQRES 16 B 390 ALA LEU THR ILE LYS TYR SER ASN GLU ILE LYS LYS GLU SEQRES 17 B 390 LYS LEU THR TRP HIS PHE GLU THR GLY LEU LYS GLY TYR SEQRES 18 B 390 LEU ASP HIS LYS LEU GLU ALA GLU THR LEU PRO ALA GLU SEQRES 19 B 390 PRO PHE ILE ILE ASP ASN PHE SER ASN GLY ASP SER TYR SEQRES 20 B 390 LEU ASP ALA VAL PHE CYS TRP CYS GLU ASP PRO SER GLU SEQRES 21 B 390 SER ILE LYS ASN SER TYR VAL ASN LEU ILE PRO THR PRO SEQRES 22 B 390 GLN ASP GLY THR HIS VAL THR GLY LEU LYS ASN GLY ILE SEQRES 23 B 390 TYR ASP ALA ILE LYS ALA TYR ILE GLU LYS ASN SER LEU SEQRES 24 B 390 SER VAL LYS ASN ILE LYS ILE THR ALA ASN ASP SER PHE SEQRES 25 B 390 ALA GLN LEU ASN TYR VAL ILE SER VAL LYS ILE THR ASN SEQRES 26 B 390 PRO GLN PHE ALA GLY GLN THR LYS GLU LYS LEU SER ASN SEQRES 27 B 390 LYS ASP VAL THR ASN PHE VAL ALA THR ALA VAL LYS ASP SEQRES 28 B 390 LEU LEU THR ILE TRP LEU ASN GLN ASN PRO ASP GLU ALA SEQRES 29 B 390 ARG GLN ILE VAL GLU ASN ILE SER LYS VAL ALA GLN LYS SEQRES 30 B 390 ARG ILE ASN ALA ASP LEU GLU HIS HIS HIS HIS HIS HIS HET CJC A 401 30 HETNAM CJC 7-({4-[(3R)-3-AMINOPYRROLIDIN-1-YL]-5-CHLORO-6-ETHYL- HETNAM 2 CJC 7H-PYRROLO[2,3-D]PYRIMIDIN-2-YL}SULFANYL)PYRIDO[2,3- HETNAM 3 CJC B]PYRAZIN-2(1H)-ONE FORMUL 3 CJC C19 H19 CL N8 O S FORMUL 4 HOH *634(H2 O) HELIX 1 1 LEU A 15 ARG A 21 1 7 HELIX 2 2 PRO A 22 TYR A 25 5 4 HELIX 3 3 PRO A 31 ALA A 48 1 18 HELIX 4 4 GLY A 85 LYS A 92 1 8 HELIX 5 13 LEU B 15 ARG B 21 1 7 HELIX 6 14 ARG B 21 THR B 26 1 6 HELIX 7 15 PRO B 31 ALA B 48 1 18 HELIX 8 16 SER B 84 LYS B 92 1 9 HELIX 9 17 VAL B 115 LEU B 121 1 7 HELIX 10 18 LYS B 170 PHE B 173 5 4 HELIX 11 19 ASN B 179 LEU B 193 1 15 HELIX 12 20 GLY B 220 GLU B 227 1 8 SHEET 1 A 2 ILE A 9 THR A 13 0 SHEET 2 A 2 LEU A 93 GLY A 97 -1 O SER A 95 N VAL A 11 SHEET 1 B 2 ILE A 64 ASP A 68 0 SHEET 2 B 2 LYS A 53 LEU A 58 -1 N ASN A 55 O ALA A 67 SHEET 1 C 2 ILE A 77 HIS A 78 0 SHEET 2 C 2 MET A 83 SER A 84 -1 O MET A 83 N HIS A 78 SHEET 1 F 2 ILE B 9 GLU B 10 0 SHEET 2 F 2 GLY B 96 GLY B 97 -1 O GLY B 97 N ILE B 9 SHEET 1 G 8 PHE B 144 ASN B 154 0 SHEET 2 G 8 ASN B 134 GLU B 141 -1 N VAL B 135 O ILE B 152 SHEET 3 G 8 SER B 122 ARG B 131 -1 N ILE B 129 O TYR B 136 SHEET 4 G 8 GLY B 161 PRO B 168 -1 O LYS B 163 N GLU B 128 SHEET 5 G 8 ILE B 64 ASP B 68 -1 N ASP B 68 O THR B 162 SHEET 6 G 8 LYS B 53 LEU B 58 -1 N THR B 57 O GLU B 65 SHEET 7 G 8 THR B 198 ASN B 203 1 O SER B 202 N LEU B 58 SHEET 8 G 8 GLU B 208 TRP B 212 -1 O LEU B 210 N TYR B 201 CISPEP 1 GLU A 227 ALA A 228 0 2.18 CISPEP 2 LEU A 231 PRO A 232 0 -9.08 CISPEP 3 LEU B 231 PRO B 232 0 -3.86 SITE 1 AC1 17 ILE A 38 ASN A 41 SER A 42 GLU A 45 SITE 2 AC1 17 ASP A 68 GLY A 72 MET A 73 ILE A 89 SITE 3 AC1 17 VAL A 115 ARG A 131 THR A 162 ILE A 164 SITE 4 AC1 17 HOH A 526 HOH A 530 HOH A 675 HOH A 791 SITE 5 AC1 17 HOH A 842 CRYST1 44.164 130.282 80.270 90.00 98.12 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022643 0.000000 0.003231 0.00000 SCALE2 0.000000 0.007676 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012584 0.00000